5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2018-08-08
Summary
Non-persistence to adjuvant hormonal therapy for breast cancer at 5 years decrease its efficacy. The objective of this study is to know the women experience (persistence, treatment changes, quality of life) and its determinants, in a french population.
Conditions
Interventions
- OTHER
-
questionnary of quality of life
Sponsors & Collaborators
-
Institut de Cancérologie de Lorraine
lead OTHER
Principal Investigators
-
LESUR ANNE, Md · Institut de Cancérologie de Lorraine
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-03
- Primary Completion
- 2017-06-03
- Completion
- 2017-06-03
Countries
- France
Study Locations
More Related Trials
-
Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer
NCT04661982 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
NCT04918082 ·Status: ACTIVE_NOT_RECRUITING
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid
NCT05140252 ·Status: COMPLETED ·Phase: NA
-
Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.
NCT04902937 ·Status: RECRUITING
-
Radiotherapy After Primary Chemotherapy for Breastcancer
NCT01279304 ·Status: COMPLETED
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING
-
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749 ·Status: NOT_YET_RECRUITING
-
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
NCT00922961 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer
NCT05850637 ·Status: COMPLETED ·Phase: PHASE2
-
FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France
NCT03884413 ·Status: COMPLETED
-
Young Breast Cancer Survivors Study
NCT05981716 ·Status: UNKNOWN
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
Praegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167 ·Status: RECRUITING
-
Follow-up in Early and Locally Advanced Breast Cancer Patients
NCT03859453 ·Status: COMPLETED
-
Patterns of Care in Hormone-receptor Positive, Advanced Breast Cancer
NCT01277926 ·Status: TERMINATED
-
Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy
NCT04203849 ·Status: ENROLLING_BY_INVITATION
-
Predictive Clinical and Biological Parameters in Breast Cancer
NCT01521676 ·Status: TERMINATED ·Phase: NA
-
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 ·Status: RECRUITING ·Phase: NA
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
NCT07165756 ·Status: RECRUITING
-
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014
NCT01503034 ·Status: COMPLETED
-
Needs Assessment After Cancer in Patients Treated for Breast Cancer
NCT03902964 ·Status: COMPLETED
-
Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT02997384 ·Status: UNKNOWN